Select your language:
Arabic Brazilian Portuguese Bulgarian Chinese Chinese Simplified Chinese Traditional Croatian Czech Danish Dutch European Spanish Filipino (Tagalog) Finnish French German Greek Hungarian Icelandic Italian Japanese Korean Latin American Spanish Norwegian Polish Portuguese Romanian Russian Serbian Slovenian Spanish Swedish Thai Welsh
Helix Research Center
  Home | About Us | News | Contact Us 


Find us on Facebook - Helix Research Center Follow us on Twitter Blogger

Helix Services Worldwide!

Auditing Big Data Analytics / Healthcare Analytics, Research Analytics etc.,
Biostatistics/Statistical Analysis Clinical Data Management (EDC)
Clinical Trial Supplies Cold Chain Management
Conferences Consulting
Contract Manufacturing Contract Research (CRO)
Healthcare Hospital and Laboratory Supplies
Imaging Marketing/Promotion
Medical Writing Mergers and Acquisitions
Packaging and Labeling Pharma Logistics
Pharmacovigilance Product Development
Publications Quality Assurance
Regulatory Affairs Seminars
Site Management (SMO, Non SMO) Staffing/Recruitment
Training Translation

For further information, please contact: OR contact us here.


Helix was established in the year 2005 as an independent academic and regulatory contract research organization in order to develop, initiate and co-ordinate clinical trials (pre clinical, pharmcodynamics, clinical phase I, II, IIb, III and post marketing and sub-economic/quality of life and indication extension global studies and local registries) relevant for the development and approval of pharmaceuticals, biologics, medical devices, APIs and Generics and centralized radiology imaging, molecular imaging, core lab, blood lab, ECG/EKG, EMG services. Since its inception, Helix has gained extensive experience in the centralized coordination and clinical projects logistic, site personnel and physicians protocol and ICH-GCP training and in the Site Set-Up and Site Closing-Out processes.

Helix undertakes all aspects of clinical research from protocol, crf/edc, patient information and consent and investigator brochure development and application submissions to competent authorities and notified bodies in India, Australasia, Germany, whole of Europe and north and south of America.

Helix focuses on single hand drug and device development. We are proud to say at Helix"scientific, regulatory and commercial expertise meets service". We offer highly specialized hospitals and clinical research facilities based clinical trials management. Our partners are highly specialized core laboratories, imaging centers, molecular imaging centralized service providers, data management to statistical analysis centers, KOL based reporting, presentations and publication (major Asian, European and US congresses and in the major peer reviewed scientific journals) centers.

Helix is in full conform to DCGI, DGFT, FDA, EC, EMEA, ICH-GCP, cGLP, cGMP, 21 CFR, ISO, HIPAA standards.

Helix promotes the concept of high quality and principles of quality management, full GxP adherence and implements quality improvements.



1. Site Selections, Investigator Selections (including PIs) and Feasibility of Identified Sites:

  • Helix assists the sponsors and CROs in the identification of potential and ICH-GCP trained Investigators
  • Helix conducts high quality feasibility for the potential site Investigators identified
  • Helix trains site staff "Fast Study Subjects Recruitment and Adherence to ICH-GCP and 21 CFR Part 11"
  • Helix visits potential investigators to ensure the adequacy of site staff with regard to Sponsor SOPs, Study Protocols, CRFs/EDCs, Patient Information and Consents, ICH-GCP, cGLP, 21CFR Part 11, Ethics Committee/MECs and IRBs, QSP-15A

2. Helix in-house work pertaining to sponsor's project/full service, single service, scope of works start-up:

  • Helix prepares site selection trip according to sponsor's SOP and budget
  • Helix collects, reviews, tracks and archives the project related documents, study protocols and amendments, CRFs/EDC - templates, Investigator Brochures, Patient Information and Consents, Ethics Committees-Applications or EC Votes/approvals, clinical drug, clinical device or import-export license, IP-Justification or T-License
  • Helix uses special mentoring strategies to facilitate the collection of documents required for making the application to DCGI
  • Helix supports the IP-justification for T-License application process and the calculations and other supporting documents needed for DGFT application
  • Helix works Hand-in-Hand, on daily basis with the Clinical Project Managers and Regulatory Affairs Managers of the sponsors
  • Helix organizes, prepares, attends or lead and presents the Sponsor Study/Protocols, CRFs, Patient Information and Consents, Drug and Device Application, Clinical Drug and Device logistic, handling and positioning, monitoring, FDA/EMEA/DCGI site audits, ICH-GCP, 21 CFR Part 11, cGLP, trial news letters and future clinical data publication
  • Helix delivers study related documents and clinical product to selected sites and offers full ICH-GCP training to site staff
  • Helix reports study and site status on daily basis to sponsor representative
  • Helix provides full clinical trial service support to busy sponsor PMs
Copyright © 2016. All rights reserved. Designed by Dinesh

* Website best viewed with resolution more than 900px width